May 3rd, 2023
SESSION I
3.00 – 3.10 pm Introduction, team structure, patient care algorithm, overview of key facilities
G. Palladini (Pavia)
3.10 – 3.30 pm Biology of the amyloid plasma cell clone and implications for treatment
M.U. Nuvolone (Pavia)
3.30 – 3.50 pm Diagnosis of systemic amyloidosis: principles and pitfalls
P. Milani (Pavia)
3.50 – 4.30 pm Clinical cases: diagnosis of systemic amyloidosis
Q&A session
R. Benvenuti (Pavia), A. Foli (Pavia)
4.30 – 4.40 pm Break
SESSION II
4.40 – 5.00 pm Staging of AL amyloidosis and design of the therapeutic strategy
G. Palladini (Pavia)
5.00 – 5.20 pm Upfront therapy
G. Palladini (Pavia)
5.20 – 5.40 pm Response assessment
P. Milani (Pavia)
May 4th, 2023
SESSION III
3.00 – 3.40 pm Clinical cases: upfront therapy of AL amyloidosis
Q&A session
R. Benvenuti (Pavia), A. Foli (Pavia)
3.40 – 4.00 pm When to treat at relapse?
Rescue therapy
P. Milani (Pavia)
4.00 – 4.40 pm Clinical cases: rescue therapy of AL amyloidosis
Q&A session
R. Benvenuti (Pavia), A. Foli (Pavia)
4.40 – 4.50 pm Break
SESSION IV
4.50 – 5.10 pm Supportive therapy and organ transplantation
A. Foli (Pavia)
5.10 – 5.50 pm General Q&A session
5.50 – 6.00 pm Closing remarks
G. Palladini (Pavia)
